Tony T. Kalajian, Sr.VP/Chief Accounting Officer at OncoCyte Corp (OCX), bought 5,000 shares at $1.31 ($7K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market purchase of $7k OCX by Sr.VP/Chief Accounting Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.